Effects of a 9-month strength training intervention on insulin, insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-1, and IGFBP-3 in 30-50-year-old women

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 12, 2002, Pages 1597-1604

  Schmitz, Kathryn H ^a,c   Ahmed, Rehana L ^a   Yee, Douglas ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BODY FAT; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STRENGTH; TRAINING;

ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; COLONIC NEOPLASMS; EXERCISE; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERVENTION STUDIES; MIDDLE AGED; PHYSICAL EDUCATION AND TRAINING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; WEIGHT LIFTING;

EID: 0036907556     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Friedenreich, C. M. Physical activity and cancer prevention: From observational to intervention research. Cancer Epidemiol. Biomark. Prev., 10: 287-301, 2001.
2. McTiernan, A., Ulrich, C., Slate, S., and Potter, J. Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control, 9: 487-509, 1998.
3. Barker, B. E., Fanger, H., and Farnes, P. Human mammary slides in organ culture. I. Methods of culture and preliminary observations on the effects of insulin. Exp. Cell Res., 35: 437-448, 1964.
4. Elias, J. J., and Armstrong, R. C. Hyperplastic and metaplastic responses of human mammary fibroadenomas and dysplasias in organ culture. J. Natl. Cancer Inst. (Bethesda), 51: 1341-1343, 1973.
5. Dideriksen, L. H., Jorgensen, L. N., and Drejer, K. Carcinogenic effect on female rats after 12 months administration of the insulin analogue B10 Asp. Diabetes, 41 (Suppl. 1): 143A, 1992.
6. Giogino, F., Belfiore, A., Milazzo, G., Costantino, A., Maddux, B., Whittaker, J., Goldfine, I. D., and Vigneri, R. Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Mol. Endocrinol., 5: 452-459, 1991.
7. Kaleko, M., Rutter, W. J., and Miller, A. D. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol., 10: 464-473, 1990.
8. Koenuma, M., Yamori, T., and Tsuruo, T. Insulin and insulin-like growth factor I stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn. J. Cancer Res., 80: 51-58, 1989.
9. Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., and Hood, N. Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J. Clin. Oncol., 20: 42-51, 2002.
10. Yu, H., and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. (Bethesda), 92: 1472-1489, 2000.
11. Byrne, C., Colditz, G. A., Willett, W. C., Speizer, F. E., Pollak, M., and Hankinson, S. E. Plasma insulin-like growth factor (IGF) 1, IGF-binding protein 3, and mammographic density. Cancer Res., 60: 3744-3748, 2000.
12. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev., 16: 3-34, 1995.
13. Sachdev, D., and Yee, D. The IGF system and breast cancer. Endocr. Relat. Cancer, 8: 197-209, 2001.
14. Giovannucci, E., Pollak, M. N., Platz, E. A., Willett, W. C., Stampfer, M. J., Majeed, N., Colditz, G. A., Speizer, F. E., and Hankinson, S. E. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomark. Prev., 9: 345-349, 2000.
15. DiGiovanni, J., Bol, D. K., Wilker, E., Beltran, L., Carbajal, S., Moats, S., Ramirez, A., Jorcano, J., and Kiguchi, K. Constitutive expression of insulin-like growth factor-I in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res., 60: 1561-1570, 2000.
16. DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltran, L., Moats, S., Ramirez, A., Jorcano, J., and Conti, C. Deregulated expression of insulin-like growth factor I in prostate epithelium leads to neoplasia in transgenic mice. Proc. Natl. Acad. Sci. USA, 97: 3455-3460, 2000.
17. Hadsell, D. L., Greenberg, N. M., Fligger, J. M., Baumrucker, C. R., and Rosen, J. M. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology, 137: 321-330, 1996.
18. Hadsell, D. L., Murphy, K. L., Bonnette, S. G., Reece, N., Laucirica, R., and Rosen, J. M. Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis. Oncogene, 19: 889-898, 2000.
19. Nam, S. Y., and Marcus, C. Growth hormone and adipocyte function in obesity. Horm. Res., 53: 87-97, 2000.
20. Reaven, G. M. Pathophysiology of insulin resistance in human disease. Physiol. Rev., 75: 473-486, 1995.
21. Helmrich, S. P., Ragland, D. R., Leung, R. W., and Paffenbarger, R. S., Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. J. Med., 325: 147-152, 1991.
22. Suikkari, A. M., Koivisto, V. A., Rutanen, E. M., Yki-Jarvinen, H., Karonen, S. L., and Seppala, M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J. Clin. Endocrinol. Metab., 66: 266-272, 1988.
23. Boni-Schnetzler, M., Schmid, C., Mary, J. L., Zimmerli, B., Meier, P. J., Zapf, J., Schwander, J., and Froesch, E. R. Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes. Mol. Endocrinol., 4: 1320-1326, 1990.
24. Lukanova, A., Toniolo, P., Akhmedkhanov, A., Hunt, K., Rinaldi, S., Zeleniuch-Jacquotte, A., Haley, N. J., Riboli, E., Stattin, P., Lundin, E., and Kaaks, R. A cross-sectional study of IGF-I determinants in women. Eur. J. Cancer Prev., 10: 443-452, 2001.
25. Voskuil, D. W., de Mesquita, H. B., Kaaks, R., van Noord, P. A., Rinaldi, S., Riboli, E., Grobbee, D. E., and Peeters, P. H. Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control. 12: 951-958, 2001.
26. Hurley, B. F., and Hagberg, J. M. Optimizing health in older persons: Aerobic or strength training? Exerc. Sport Sci. Rev., 26: 61-89, 1998.
27. Miller, J. P., Pratley, R. E., Goldberg, A. P., Gordon, P., Rubin, M., Treuth, M. S., Ryan, A. S., and Hurley, B. F. Strength training increases insulin action in healthy 50- to 65-yr-old men. J. Appl. Physiol., 77: 1122-1127, 1994.
28. Ryan, A. S., Pratley, R. E., Elahi, D., and Goldberg, A. P. Resistive training increases fat-free mass and maintains RMR despite weight loss in postmenopausal women. J. Appl. Physiol., 79: 818-823, 1995.
29. Zachwieja, J. J., Toffolo, G., Cobelli, C., Bier, D. M., and Yarasheski, K. E. Resistance exercise and growth hormone administration in older men: Effects on insulin sensitivity and secretion during a stable-label intravenous glucose tolerance test. Metabolism, 45: 254-260, 1996.
30. PAR-Q Validation Report: British Columbia Ministry of Health, May 1978.
31. Ainsworth, B. E., La Monte, M. J., Whitt, M. C., Irwin, M. L., and Drowatzky, K. Development and Validation of a Physical Activity Questionnaire to Assess Moderate Intensity Activity in Minority Women, Ages 40 and Older. Bethesda, MD: NIH Women's Health Community Research Conference, 2000.
32. Pereira, M. A., FitzGerald, S. J., Gregg, E. W., Joswiak, M. L., Ryan, W. J., Suminski, R. R., Utter, A. C., and Zmuda, J. M. A collection of physical activity questionnaires for health-related research. Med. Sci. Sports Exerc., 29 (Suppl. 6): S1-S205, 1997.
33. WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organization, Division of Noncommunicable Diseases, Programme of Nutrition, Family and Reproductive Health, 1997.
34. Ryan, A. S., Hurlbut, D. E., Lott, M. E., Ivey, F. M., Fleg, J., Hurley, B. F., and Goldberg, A. P. Insulin action after resistive training in insulin resistant older men and women. J. Am. Geriatr. Soc., 49: 247-253, 2001.
35. Jakicic, J. M., Winters, C., Lang, W., and Wing, R. R. Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women: A randomized trial. J. Am. Med. Assoc., 282: 1554-1560, 1999.
36. Cullinen, K., and Caldwell, M. Weight training increases fat-free mass and strength in untrained young women. J. Am. Diet. Assoc., 98: 414-418, 1998.
37. Chilibeck, P. D., Calder, A., Sale, D. G., and Webber, C. E. Twenty weeks of weight training increases lean tissue mass but not bone mineral mass or density in healthy, active young women. Can. J. Physiol. Pharmacol., 74: 1180-1185, 1996.
38. Broeder, C. E., Burrhus, K. A., Svanevik, L. S., and Wilmore, J. H. The effects of either high-intensity resistance or endurance training on resting metabolic rate. Am. J. Clin. Nutr., 55: 802-810, 1992.
39. Campbell, W. W., Crim, M. C., Young, V. R., and Evans, W. J. Increased energy requirements and changes in body composition with resistance training in older adults. Am. J. Clin. Nutr., 60: 167-175, 1994.
40. Nelson, M. E., Fiatarone, M. A., Morganti, C. M., Trice, I., Greenberg, R. A., and Evans, W. J. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial. J. Am. Med. Assoc., 272: 1909-1914, 1994.
41. Nichols, J. F., Omizo, D. K., Peterson, K. K., and Nelson, K. P. Efficacy of heavy-resistance training for active women over sixty: Muscular strength, body composition, and program adherence. J. Am. Geriatr. Soc., 41: 205-210, 1993.
42. Taaffe, D. R., Pruitt, L., Reim, J., Butterfield, G., and Marcus, R. Effect of sustained resistance training on basal metabolic rate in older women. J. Am. Geriatr. Soc., 43: 465-471, 1995.
43. Nicklas, B. J., Ryan, A. J., Treuth, M. M., Harman, S. M., Blackman, M. R., Hurley, B. F., and Rogers, M. A. Testosterone, growth hormone and IGF-I responses to acute and chronic resistive exercise in men aged 55-70 years. Int. J. Sports Med., 16: 445-450, 1995.
44. Treuth, M. S., Ryan, A. S., Pratley, R. E., Rubin, M. A., Miller, J. P., Nicklas, B. J., Sorkin, J., Harman, S. M., Goldberg, A. P., and Hurley, B. F. Effects of strength training on total and regional body composition in older men. J. Appl. Physiol., 77: 614-620, 1994.
45. Pyka, G., Taaffe, D. R., and Marcus, R. Effect of a sustained program of resistance training on the acute growth hormone response to resistance exercise in older adults. Horm. Metab. Res., 26: 330-333, 1994.
46. Bermon, S., Ferrari, P., Bernard, P., Altare, S., and Dolisi, C. Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiol. Scand., 165: 51-56, 1999.
47. Marx, J. O., Ratamess, N. A., Nindl, B. C., Gotshalk, L. A., Volek, J. S., Dohi, K., Bush, J. A., Gomez, A. L., Mazzetti, S. A., Fleck, S. J., Hakkinen, K., Newton, R. U., and Kraemer, W. J. Low-volume circuit versus high-volume periodized resistance training in women. Med. Sci. Sports Exerc., 33: 635-643, 2001.
48. Borst, S. E., De Hoyos, D. V., Garzarella, L., Vincent, K., Pollock, B. H., Lowenthal, D. T., and Pollock, M. L. Effects of resistance training on insulin-like growth factor-I and IGF binding proteins. Med. Sci. Sports Exerc., 33: 648-653, 2001.
49. Koziris, L. P., Hickson, R. C., Chatterton, R. T., Jr., Groseth, R. T., Christie, J. M., Goldflies, D. G., and Unterman, T. G. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J. Appl. Physiol., 86: 1436-1442, 1999.
50. Roelen, C. A., de Vries, W. R., Koppeschaar, H. P., Vervoorn, C., Thijssen, J. H., and Blankenstein, M. A. Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training. Int. J. Sports Med., 18: 238-241, 1997.
51. McCall, G. E., Byrnes, W. C., Fleck, S. J., Dickinson, A., and Kraemer, W. J. Acute and chronic hormonal responses to resistance training designed to promote muscle hypertrophy. Can. J. Appl. Physiol., 24: 96-107, 1999.
52. Centers for Disease Control. Physical Activity and Health: A Report to the Surgeon General. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.
53. Ahmed, R., Schmitz, K. H., and Yee, D. Strength training induced changes in body composition, fasting insulin, and insulin-like growth factor. Proc. Am. Assoc. Cancer Res., 43: 1148-1149, 2002.
54. Bonanni, B., Johansson, H., Gandini, S., Guerrieri-Gonzaga, A., Torrisi, R., Sandri, M. T., Cazzaniga, M., Mora, S., Robertson, C., Lien, E. A., and Decensi, A. Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women. Breast Cancer Res. Treat., 69: 21-27, 2001.
55. Bruning, P. F., Van Doorn, J., Bonfrer, J. M., Van Noord, P. A., Korse, C. M., Linders, T. C., and Hart, A. A. Insulin-like growth factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int. J. Cancer, 62: 266-270, 1995.
56. Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., and Pollak, M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351: 1393-1396, 1998.
57. Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., and Stampfer, M. J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. (Bethesda), 91: 620-625, 1999.
58. Kaaks, R., Toniolo, P., Akhmedkhanov, A., Lukanova, A., Biessy, C., Dechaud, H., Rinaldi, S., Zeleniuch-Jacquotte, A., Shore, R. E., and Riboli, E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J. Natl. Cancer Inst. (Bethesda), 92: 1592-1600, 2000.
59. Yee, D., and Lee, A. V. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J. Mamm. Gland Biol. Neoplasia, 5: 107-115, 2000.
60. Wu, Y., Yakar, S., Zhao, L., Hennighausen, L., and LeRoith, D. Circulating insulin-like growth factor I levels regulate colon cancer growth and metastasis. Cancer Res., 62: 1030-1035, 2002.
61. Yakar, S., Green, J. E., and Le Roith, D. Serum IGF-I levels as a risk marker in mammary tumors. Proc. Endocrine. Soc., Abstract P1-242, 2001.
62. Ambrosio, M. R., Valentini, A., Trasforini, G., Minuto, F., Ghigo, E., Cella, S., Margutti, A., Pansini, R., and degli Uberti, E. C. Function of the GH/IGF-1 axis in healthy middle-aged male runners. Neuroendocrinology, 63: 498-503, 1996.